首页> 外国专利> THERMALLY-TARGETED DELIVERY OF MEDICAMENTS INCLUDING DOXORUBICIN

THERMALLY-TARGETED DELIVERY OF MEDICAMENTS INCLUDING DOXORUBICIN

机译:包括阿霉素在内的药物的靶向治疗

摘要

Elastin-like polypeptide (ELP) serves as a vector for thermally-targeted delivery of therapeutics, including cytotoxic chemotherapeutic drugs such as doxorubicin. Examples of an ELP-based delivery vehicle can comprise: (1) a cell penetrating peptide, such as a Tat protein, (2) ELP, and (3) the lysosomally degradable glycylphenylalanylleucylglycine (GFLG) spacer and a cysteine residue conjugated to therapeutic such as doxorubicin, or a analog thereof.
机译:弹性蛋白样多肽(ELP)用作热靶向治疗药物的载体,包括细胞毒性化疗药物(如阿霉素)。基于ELP的递送载体的实例可包括:(1)细胞穿透肽,例如Tat蛋白,(2)ELP,和(3)溶酶体可降解的糖基苯基丙氨酰亮氨基甘氨酸(GFLG)间隔基和与治疗剂偶联的半胱氨酸残基作为阿霉素或其类似物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号